Brachytherapy for benign fundus lesions

References

• Stallard HB. Retinoblastoma treated with radioactive applicators. In: Acta XVIII Concilium Ophthalmologicum. 1958. 2): 1360-9
   Google Scholar
• Shields CL, Shields JA, De Potter P, et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology 1993;100(2):216-24
   PubMed Web of Science ®Google Scholar
• Stallard HB. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966;50(3):147-55
   PubMed Web of Science ®Google Scholar
• Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119(7):969-82
   PubMedGoogle Scholar
• Hungerford JL. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Experiment Ophthalmol 2003;31(1):8-13
   PubMed Web of Science ®Google Scholar
• Nag S, Quivey JM, Earle JD, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003;56(2):544-55
   PubMed Web of Science ®Google Scholar
• Kirwan JF, Constable PH, Murdoch IE, Khaw PT. Beta irradiation: new uses for an old treatment: a review. Eye (Lond) 2003;17(2):207-15
   PubMed Web of Science ®Google Scholar
• Ali AM, Thariat J, Bensadoun RJ, et al. The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions. Cancer Radiother 2011;15(2):140-7
   PubMed Web of Science ®Google Scholar
• Maher ER, Moore AT. Von Hippel-Lindau disease. Br J Ophthalmol 1992;76(12):743-5
   PubMedGoogle Scholar
• Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999;117(3):371-8
   PubMedGoogle Scholar
• Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol 2001;46(2):117-42
   PubMed Web of Science ®Google Scholar
• Schmidt D, Neumann HP. Retinal vascular hamartoma in von Hippel-Lindau disease. Arch Ophthalmol 1995;113(9):1163-7
   PubMedGoogle Scholar
• Singh AD, Nouri M, Shields CL, et al. Treatment of retinal capillary hemangioma. Ophthalmology 2002;109(10):1799-806
   PubMed Web of Science ®Google Scholar
• Augsburger JJ, Shields JA, Goldberg RE. Classification and management of hereditary retinal angiomas. Int Ophthalmol 1981;4(1-2):93-106
   PubMed Web of Science ®Google Scholar
• Schmidt D, Natt E, Neumann HP. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur J Med Res 2000;5(2):47-58
   PubMedGoogle Scholar
• Apple DJ, Goldberg MF, Wyhinny GJ. Argon laser treatment of von Hippel-Lindau retinal angiomas. II. Histopathology of treated lesions. Arch Ophthalmol 1974;92(2):126-30
   PubMedGoogle Scholar
• Annesley WH Jr, Leonard BC, Shields JA, Tasman WS. Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977;83(3 Pt 1):OP446-53
   PubMedGoogle Scholar
• Kreusel KM, Bornfeld N, Lommatzsch A, et al. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 1998;105(8):1386-92
   PubMed Web of Science ®Google Scholar
• Raja D, Benz MS, Murray TG, et al. Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes. Ophthalmology 2004;111(1):150-3
   PubMed Web of Science ®Google Scholar
• Sachdeva R, Dadgostar H, Kaiser PK, et al. Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol 2010;88(8):e334-40
   PubMed Web of Science ®Google Scholar
• Dahr SS, Cusick M, Rodriguez-Coleman H, et al. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina 2007;27(2):150-8
   PubMed Web of Science ®Google Scholar
• Kwan AS, Ramkissoon YD, Gregor ZJ. Surgical management of retinal capillary hemangioblastoma associated with retinal detachment. Retina 2008;28(8):1159-62
   PubMed Web of Science ®Google Scholar
• Lane CM, Turner G, Gregor ZJ, Bird AC. Laser treatment of retinal angiomatosis. Eye (Lond) 1989;3(Pt 1):33-8
   PubMedGoogle Scholar
• Gorin MB. Von Hippel-Lindau disease: clinical considerations and the use of fluorescein-potentiated argon laser therapy for treatment of retinal angiomas. Semin Ophthalmol 1992;7(3):182-91
   PubMedGoogle Scholar
• Gass JD. Treatment of retinal vascular anomalies. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977;83(3 Pt 1):OP432-9
   PubMedGoogle Scholar
• Moore RF. Presidential address. Trans Am Ophthalmol Soc 1935;55:3
   Google Scholar
• Palmer JD, Gragoudas ES. Advances in treatment of retinal angiomas. Int Ophthalmol Clin 1997;37(4):159-70
   PubMedGoogle Scholar
• Goldberg MF, Koenig S. Argon laser treatment of von Hippel-Lindau retinal angiomas. I. Clinical and angiographic findings. Arch Ophthalmol 1974;92(2):121-5
   PubMedGoogle Scholar
• Goldberg MF, Duke JR. Von Hippel-Lindau disease. Histopathologic findings in a treated and an untreated eye. Am J Ophthalmol 1968;66(4):693-705
   PubMed Web of Science ®Google Scholar
• Balazs E, Berta A, Rózsa L, et al. Hemodynamic changes after ruthenium irradiation of Hippel’s angiomatosis. Ophthalmologica 1990;200(3):128-32
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol 1995;113(5):615-23
   PubMedGoogle Scholar
• Shields CL, Honavar SG, Shields JA, et al. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001;108(12):2237-48
   PubMed Web of Science ®Google Scholar
• McCabe CM, Mieler WF. Six-year follow-up of an idiopathic retinal vasoproliferative tumor. Arch Ophthalmol 1996;114(5):617
   PubMedGoogle Scholar
• Jain K, Berger AR, Yucil YH, McGowan HD. Vasoproliferative tumours of the retina. Eye (Lond) 2003;17(3):364-8
   PubMed Web of Science ®Google Scholar
• Lafaut BA, Meire FM, Leys AM, et al. Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 1999;237(12):1033-8
   PubMed Web of Science ®Google Scholar
• Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol 2000;84(10):1162-9
   PubMed Web of Science ®Google Scholar
• Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol 2006;90(4):447-50
   PubMed Web of Science ®Google Scholar
• Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol 2008;126(9):1245-51
   PubMedGoogle Scholar
• Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 2001;131(5):561-71
   PubMed Web of Science ®Google Scholar
• Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol 2003;14(3):142-9
   PubMedGoogle Scholar
• Augsburger JJ, Shields JA, Moffat KP. Circumscribed choroidal hemangiomas: long-term visual prognosis. Retina 1981;1(1):56-61
   PubMedGoogle Scholar
• Baselga E. Sturge-Weber syndrome. Semin Cutan Med Surg 2004;23(2):87-98
   PubMed Web of Science ®Google Scholar
• Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge-Weber syndrome: a review. Pediatr Neurol 2004;30(5):303-10
   PubMed Web of Science ®Google Scholar
• Anand R, Augsburger JJ, Shields JA. Circumscribed choroidal hemangiomas. Arch Ophthalmol 1989;107(9):1338-42
   PubMedGoogle Scholar
• Sanz-Marco E, Gallego R, Diaz-Llopis M. Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol 2011;2(1):84-90
   PubMedGoogle Scholar
• Arevalo JF, Arias JD, Serrano MA. Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma. Arch Ophthalmol 2011;129(10):1373-5
   PubMedGoogle Scholar
• Thapa R, Shields CL. Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome. Eur J Ophthalmol 2013;23(6):922-4
   PubMed Web of Science ®Google Scholar
• Krema H, Yousef YA, Durairaj P, Santiago R. Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: a report of 2 cases. JAMA Ophthalmol 2013;131(5):681-3
   PubMed Web of Science ®Google Scholar
• Tanabe H, Sahashi K, Kitano T, et al. Effects of oral propranolol on circumscribed choroidal hemangioma: a pilot study. JAMA Ophthalmol 2013;131(12):1617-22
   PubMed Web of Science ®Google Scholar
• Zografos L, et al. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol 1996;121(2):190-9
   PubMed Web of Science ®Google Scholar
• Madreperla SA, Hungerford JL, Plowman PN, et al. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology 1997;104(11):1773-8; discussion 1779
   PubMed Web of Science ®Google Scholar
• Hannouche D, Frau E, Desjardins L, et al. Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serious retinal detachment. Ophthalmology 1997;104(11):1780-4
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998;236(5):365-74
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth UM, Michels S, Kusserow C, et al. Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology 2002;109(12):2284-94
   PubMed Web of Science ®Google Scholar
• Madreperla SA. Choroidal hemangioma treated with photodynamic therapy using verteporfin. Arch Ophthalmol 2001;119(11):1606-10
   PubMedGoogle Scholar
• Robertson DM. Photodynamic therapy for choroidal hemangioma associated with serous retinal detachment. Arch Ophthalmol 2002;120(9):1155-61
   PubMedGoogle Scholar
• Singh AD, Kaiser PK, Sears JE, et al. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol 2004;88(11):1414-18
   PubMed Web of Science ®Google Scholar
• Garcia-Arumi J, Ramsay LS, Guraya BC. Transpupillary thermotherapy for circumscribed choroidal hemangiomas. Ophthalmology 2000;107(2):351-6; discussion 357
   PubMed Web of Science ®Google Scholar
• Fuchs AV, Mueller AJ, Grueterich M, Ulbig MW. Transpupillary thermotherapy (TTT) in circumscribed choroidal hemangioma. Graefes Arch Clin Exp Ophthalmol 2002;240(1):7-11
   PubMed Web of Science ®Google Scholar
• Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye (Lond) 2009;24(3):459-67
   PubMed Web of Science ®Google Scholar
• Schilling H, Bornfeld N. Long-term results after low-dose ocular irradiation for choroidal hemangiomas. Curr Opin Ophthalmol 1998;9(3):51-5
   PubMedGoogle Scholar
• Hocht S, Wachtlin J, Bechrakis NE, et al. Proton or photon irradiation for hemangiomas of the choroid? A retrospective comparison. Int J Radiat Oncol Biol Phys 2006;66(2):345-51
   PubMed Web of Science ®Google Scholar
• Murthy R, et al. Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal haemangioma in Sturge-Weber syndrome. Indian J Ophthalmol 2005;53(4):274-5
   PubMedGoogle Scholar
• Arepalli S, Shields CL, Kaliki S, et al. Diffuse choroidal hemangioma management with plaque radiotherapy in 5 cases. Ophthalmology 2013;120(11):2358-9; 2359 e1-2
   PubMed Web of Science ®Google Scholar
• Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24(Suppl):335-610
   PubMedGoogle Scholar
• Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32(6):375-413
   PubMed Web of Science ®Google Scholar
• Gelisken O, Yazici B. Radiation therapy in exudative age-related macular degeneration. Semin Ophthalmol 1999;14(1):27-34
   PubMedGoogle Scholar
• Shields CL, Mashayekhi A, Sun H, et al. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Ophthalmology 2006;113(11):2087-92
   PubMed Web of Science ®Google Scholar
• Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127(2):170-7
   PubMed Web of Science ®Google Scholar
• Eldebawy E, Patrocinio H, Evans M, et al. Stereotactic radiotherapy as an alternative to plaque brachytherapy in retinoblastoma. Pediatr Blood Cancer 2010;55(6):1210-12
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993;77(5):265-73
   PubMed Web of Science ®Google Scholar
• A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration. Ophthalmology 1999;106(12):2239-47
   PubMed Web of Science ®Google Scholar
• Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev(5):CD004004
   Google Scholar
• Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355(14):1432-44
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355(14):1419-31
   PubMed Web of Science ®Google Scholar
• Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol 2007;143(4):679-80
   PubMed Web of Science ®Google Scholar
• Petrarca R, Jackson TL. Radiation therapy for neovascular age-related macular degeneration. Clin Ophthalmol 2011;5:57-63
   PubMedGoogle Scholar
• Stefansson E, Landers MB 3rd, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc 1981;79:307-34
   PubMedGoogle Scholar
• Feigl B. Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 2009;28(1):63-86
   PubMed Web of Science ®Google Scholar
• Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110(4):681-6
   PubMed Web of Science ®Google Scholar
• Petrarca R, Richardson M, Douiri A, et al. Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results. Retina 2013;33(6):1232-40
   PubMed Web of Science ®Google Scholar
• Avila MP, Farah ME, Santos A, et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol 2009;93(3):305-9
   PubMed Web of Science ®Google Scholar
• Dugel PU, Bebchuk JD, Nau J, et al. Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET). Ophthalmology 2013;120(2):317-27
   PubMed Web of Science ®Google Scholar
• Dugel PU, Petrarca R, Bennett M, et al. Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE study: twelve-month safety and efficacy results. Ophthalmology 2012;119(7):1425-31
   PubMed Web of Science ®Google Scholar
• Jackson TL, Chakravarthy U, Kaiser PK, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology 2013;120(9):1893-900
   PubMed Web of Science ®Google Scholar
• Eng TY, Boersma MK, Fuller CD, et al. The role of radiation therapy in benign diseases. Hematol Oncol Clin North Am 2006;20(2):523-57
   PubMed Web of Science ®Google Scholar
• Rohrschneider K, Burk RO, Bornfeld N, Völcker HE. [Capillary hemangioma of the retina. Laser scanning tomography follow-up after radiotherapy]. Fortschr Ophthalmol 1991;88(6):623-8
   PubMedGoogle Scholar
• Houwer A. von Hipples disease: retinal angiomatosis. Am J Ophthalmol 1919;2:820
   Google Scholar
• Wong WT, Chew EY. Ocular von Hippel-Lindau disease: clinical update and emerging treatments. Curr Opin Ophthalmol 2008;19(3):213-17
   PubMed Web of Science ®Google Scholar